Boltz and Excelra Bring Curated Data to AI Drug Discovery
AI drug discovery models need more than accurate predictions of how molecules interact with biological targets. They also need to identify compounds with properties that make them suitable for further development, including solubility and permeability. Boltz PBC is partnering with Excelra to strengthen that part of its small-molecule discovery pipeline. The collaboration brings Excelra’s curated…
